NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines

The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UK advises limiting AstraZeneca in under-30s amid clot issue

OPINION: CDC has public health messaging problems about the Covis pandemic

ANALYSIS: Why COVIDF-19 conspiracy theories persist

As the world struggles to break the grip of COVID-19, psychologists and misinformation experts are studying why the pandemic spawned so many conspiracy theories, which have led people to eschew masks, social distancing and vaccines.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

‘Vaccine Passports’ Emerge as the Next Coronavirus political Divide, White House aloof

...Around the country, businesses, schools and politicians are considering “vaccine passports” — digital proof of vaccination against the coronavirus — as a path to reviving the economy and getting Americans back to work and play. Businesses especially fear that too many customers will stay away unless they can be assured that the other patrons have been inoculated.

But the idea is raising charged legal and ethical questions: Can businesses require employees or customers to provide proof — digital or otherwise — that they have been vaccinated when the coronavirus vaccine is ostensibly voluntary?

Problem, Solution, SitRep, or ?: 

AstraZeneca's coronavirus vaccine plausibly linked to rare brain clots, European regulators say

India could resume AstraZenca vaccine exports by June -- AP interview

NEW DELHI (AP) — The world’s largest vaccine maker, based in India, will be able to restart exports of AstraZeneca doses by June if new coronavirus infections subside in the country, its chief executive said Tuesday.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

AstraZeneca: Researchers race to understand why handful of patients develop blot clots

Some European countries considering mixing COVID-19 vaccines

It may take all year before all willing adults in some states get vaccinated

Six months later, a third of COVID-19 patients have been diagnosed psychiatric or neurological illness

Six months after being diagnosed with Covid-19, 1 in 3 patients also had experienced a psychiatric or neurological illness, mostly mood disorders but also strokes or dementia, a large new study shows.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Almost 80 percent of teachers, childcare workers have received at least one COVID-19 vaccine dose

Health-care workers describe high coronavirus-related stress during the pandemic.

Worry, exhaustion, constantly changing safety rules and long hours of wearing PPE are just a few things America’s health-care workers cite as the hardest parts of going to work on the front lines of the coronavirus pandemic.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

AstraZeneca developments: Oxford suspends trial with children, European official says casual link with rare blot cots

The second dose of vaccines (except J&J) is still needed for fullest protection

Last Saturday, the U.S. hit a new high for the number of daily vaccinations: 4 million. The record day came as vaccinations have steadily risen over recent weeks, bringing the daily average to more than 3 million.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global RSS
howdy folks
Page loaded in 1.052 seconds.